Finance

Beta
Lists
NANO:EPA
Nanobiotix SA
€30.14
-3.58%
(-1.12) 1D
Jun 3, 5:37:32 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for NANO...
Open
€32.06
High
€32.36
Low
€30.00
Mkt. cap
1.50B
Avg. vol.
296.79K
Volume
224.15K
52-wk high
€47.66
52-wk low
€3.58
EPS
-€0.50
Shares outstanding
50.62M
No. of employees
100
Open
€32.06
High
€32.36
Low
€30.00
Mkt. cap
1.50B
Avg. vol.
296.79K
Volume
224.15K
52-wk high
€47.66
52-wk low
€3.58
EPS
-€0.50
Shares outstanding
50.62M
No. of employees
100
News stories
From sources across the web
Profile
Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients. The company is headquartered in Paris, with additional corporate offices in New York and Massachusetts. Wikipedia
About Nanobiotix SA
CEOLaurent Levy
Employees100
Founded2003
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
13.32M
13.32M
2.98M
2.98M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
7.26M
7.26M
4.29M
4.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.65M
5.65M
4.53M
4.53M
Operating expense
12.91M
12.91M
8.83M
8.83M
Total operating expenses
12.91M
12.91M
8.83M
8.83M
Operating income
407.50K
407.50K
-5.85M
-5.85M
Other non operating income
500.00
500.00
-8.50K
-8.50K
EBT including unusual items
-2.69M
-2.69M
-9.29M
-9.29M
EBT excluding unusual items
-3.20M
-3.20M
-8.57M
-8.57M
Income tax expense
3.00K
3.00K
-1.50K
-1.50K
Effective tax rate
-0.11%
-0.11%
0.02%
0.02%
Other operating expenses
-
-
-
-
Net income
-2.69M
-2.69M
-9.29M
-9.29M
Net profit margin
-20.21%
-20.21%
-311.97%
-311.97%
Earnings per share
-
-
-
-
Interest and investment income
299.00K
299.00K
193.50K
193.50K
Interest expense
-2.12M
-2.12M
-3.08M
-3.08M
Net interest expenses
-1.82M
-1.82M
-2.88M
-2.88M
Depreciation and amortization charges
-
-
-
-
EBITDA
545.50K
545.50K
-5.79M
-5.79M
Gain or loss from assets sale
-
-
76.50K
76.50K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more